More research first

Few sentences sound more responsible inside a company than this: let’s do more research first. Nobody says it with bad intentions. It is usually offered as a brake on recklessness.

It often follows What makes us different. Once positioning stops being treated as a wording problem, the next call still feels risky. Many businesses reach for something external to make commitment feel safer.

A founder wants nerve before committing budget. A leadership team wants evidence before changing position. Marketing wants cover before proposing something that may not look neat in a dashboard. Sales wants reassurance that the message will land.

Product wants validation that the market really cares. Research, in that moment, sounds like maturity.

And sometimes it is.

Some decisions do need more evidence. Some companies really are guessing. Some products are badly understood. Some markets are changing.

Some assumptions are so comfortable internally that they need testing from the outside. A book that argued against research would be a silly book.

When research becomes a brake

The trouble starts when research stops being a tool for reducing uncertainty and becomes a way of postponing commitment, laundering politics, or protecting people from having to make a difficult call.

At that point the phrase becomes cover for decisions the company does not yet want to own. A surprising number of weak marketing choices survive because the deck looks rigorous enough to delay the call.

A company says it wants to know what buyers think, but really wants confirmation that its existing message is sensible. It says it wants category insight, but really wants a safer reason not to spend yet.

It says it needs more data before broadening its reach, simplifying its proposition, raising its price, or committing to a creative direction, but often what is missing is the nerve to commit.

Research is then asked to do emotional work. It is asked to make inherently risky choices feel certain and externally authorised.

The same timing pressure sits underneath: most buyers are out of market at any one time, so research that only chases active demand still leaves most of the category untouched.

By this point, a pattern should be familiar. The business has learned to prefer what is visible, precise, attributable, and defensible. Research slots neatly into that habit. It can make leadership feel serious without necessarily improving decision quality.

The phrase itself helps. Research sounds clean, neutral, adult, and hard to object to.

No founder is going to say, “let’s look for a respectable way not to make this decision yet.” They say, “let’s gather more evidence.”

Evidence does not arrive into a neutral environment. Companies commission research with hypotheses already forming. They interpret findings through internal incentives.

They focus on what is easy to ask and easy to quote. They over-weight what buyers say clearly in an interview and under-weight what markets reveal more slowly through behaviour. Sometimes they ask research to settle questions it cannot really settle.

What evidence cannot settle

Take positioning. This is where What makes us different meets research misuse. A business runs a few interviews, hears that buyers “care about integration” or “want simplicity” or “need more reassurance”, then treats those statements as if they settle how the company should frame itself strategically.

But buyer interviews do not, on their own, tell you which frame will create the strongest market position. They tell you something useful about what people say, notice, recall, or worry about.

Valuable. Not decisive.

The same thing happens in creative review. A company shows messaging or campaign routes to a small set of respondents, then treats mild preference data as if it predicts future market effect.

The risk sits in treating thin preference testing as if it measures creative effectiveness. Kantar’s guidance on measuring creative effectiveness makes the useful distinction between short-term sales effects and longer-term brand equity.

The safest, most immediately agreeable option often performs well in that kind of environment because thin preference testing rarely rewards memorability, distinctiveness, or long-term brand effect. What the company calls insight may simply be a formalised version of its existing taste for caution.

Each earlier mistake reshapes what research gets commissioned to prove. A business that overvalues visible demand will ask research to confirm that buyers want practical, immediate messages.

A business that overvalues targeting will ask research to validate narrower segments and more specific language. A business that treats brand as deferrable will use research to justify more immediate activity.

A business that splits brand from performance will often let short-term response data outrank broader market learning. A business with no clear strategy will commission research that produces interesting material but not sharper choices.

The research may be sound. The decision frame around it often is not.

That is why the sentence “the safest and most researched decision is usually the sensible one” needs much more suspicion than it gets. The safest decision is often only the one with the lowest internal career risk.

Lowest internal career risk and highest commercial upside often point in different directions.

A founder approves a conservative campaign because nobody can accuse it of being silly. A marketing lead sticks with rational product messaging because the interviews did not explicitly ask for bolder work.

A pricing decision gets watered down because the business overreacts to stated resistance. A repositioning gets delayed because the evidence is “not conclusive enough”. A brand investment gets postponed because there is no research deck proving the exact payback window.

In each case, research may be present. But what is really being optimised is defensibility.

Inside organisations, effectiveness is only one pressure. Defensibility matters too: to colleagues, boards, investors, and future versions of themselves.

Marketing makes that pressure worse because the outcomes are probabilistic and the time horizons differ. The visible and the defensible win prestige over the plausible but less tidy.

Les Binet and Peter Field’s The Long and the Short of It describes the tension between short-term response activity and long-term brand-building, including the danger of treating very short-term online metrics as primary performance measures. The B2B Institute’s work on long-term and short-term effectiveness applies a similar tension to B2B: companies often overfeed what can be seen and counted now, even when longer-term effects matter materially to growth.

The useful discipline is knowing what different kinds of evidence can and cannot do.

Research can help a company hear the market’s language more clearly. It can expose assumptions that only existed internally. It can reveal buyer anxieties, switching triggers, category confusion, and awkward hand-offs in the buying process.

It can test whether the company is understood at all. It can help prioritise segments, use cases, and objections.

Then judgement has to take over.

A practical rule helps here. Use primary research and reliable datasets for factual and causal claims. Use benchmarks and surveys as directional signals about what companies are doing or believing. Use anecdotes to surface patterns, but label them as examples rather than proof. A useful output should force a stop, start, or continue call with a named owner - not another month of familiar options in a deck.

Research does not choose the positioning for you. It does not choose the price for you. It does not tell you exactly how bold to be creatively. It does not settle the right balance between short-term capture and long-term market presence.

Commercial risk remains inside decisions that matter.

Founders often want research to do more than that because leadership is lonely. A research deck can feel like borrowed certainty. It can turn “I think this is the right call” into “the market told us this is the right call”. That is emotionally useful.

It is also dangerous, because markets rarely speak in one voice clearly enough to absolve leadership of judgement.

Research as input

A simple example makes the trap clearer. Imagine two companies preparing to reposition.

Company Cautious commissions a broad set of interviews, a messaging survey, and a preference test on alternative routes. The results are helpful but unsurprising.

Buyers say they care about trust, ease, and outcomes. They respond reasonably well to language that sounds clear and professional. Nothing in the findings strongly endorses a sharper, more distinctive position.

So the company settles on the safest route - sensible language, familiar claims, minimal departure from the category norm. Internally, the decision is easy to defend because it is well researched.

Company Judgement also commissions research, but uses it differently.

It looks for where buyers are confused, which problems actually trigger action, what alternatives are being considered, and which claims feel overfamiliar in the category. Then leadership makes a strategic decision the research did not and could not make on its own.

It chooses a clearer, more selective position, accepts that not everyone in testing will prefer it, and uses the research as input rather than permission.

From the inside, Company Cautious feels safer. From the market’s point of view, Company Judgement may be much easier to notice, place, and remember.

That is the difference between research as input and research as alibi.

The same thing happens with pricing. Ask buyers whether they want a higher price and you already know the answer. Ask whether they would prefer more flexibility, lower risk, or more included value and you will get thoughtful comments.

None of that settles what the company should charge. The research literature on willingness to pay has long recognised the problem of hypothetical bias when people are asked to state what they would pay rather than make an actual purchase decision.

Pricing also involves value, market context, and commercial model.

Research can inform the decision. The company still has to make it.

It also happens with brand. If a company only believes what can be stated plainly in an interview, it will usually underinvest in the cumulative effects of recognisability, consistency, repeated exposure, and remembered cues.

The Ehrenberg-Bass Institute describes Category Entry Points as the thoughts category buyers have as they move into purchase situations. That evidence works differently from an interview quote. It captures effects buyers may struggle to describe directly: familiarity, legitimacy, remembered cues, and the sense that one supplier feels easier to choose later - including for buyers who were out of market when the study ran.

Companies need to avoid asking research to validate only the things buyers can easily verbalise in the moment.

A better reading of the B2B effectiveness literature points to a less comfortable conclusion: some market effects are cumulative, distributed, and visible only over longer periods than internal decision cycles prefer.

A more useful standard begins by lowering the fantasy of certainty.

A better question is: do we understand the decision well enough to make it with open eyes?

That is a different threshold from avoiding criticism. Avoiding criticism produces long decks, cautious options, and internally comfortable outcomes.

Making the decision with open eyes asks whether the company has learned what it needed to learn, and whether the remaining uncertainty is the kind that only commitment can resolve.

Some uncertainty is not reducible in advance. A business can learn its way to a better decision. It cannot always research its way to a risk-free one.

That is especially true in positioning, pricing, creative, and brand investment. These are not fields in which the most commercially useful decision always looks the most consensual in a workshop.

Sometimes the right decision is simply the one the business is willing to back consistently enough for the market to experience it properly.

In that sense, too much research can become a kind of instability.

The homepage keeps changing because new interviews produce slightly different wording. The pitch keeps rewriting because the last call raised a new objection. The creative gets softened because early feedback found it “a bit much”.

The strategy keeps expanding because research surfaced one more audience or one more possible use case. Nothing settles because every new input is treated as a reason to reopen the choice.

The business calls this listening.

What research is for

The practical answer is better discipline around what research is for.

Good research should help the company hear the market more clearly, spot blind spots, understand buying situations and objections, and improve judgement. It should not be expected to remove all uncertainty, settle every strategic choice mechanically, protect everybody from accountability, or substitute for leadership.

A founder-facing way to put it is this.

Research should reduce the chance that you are wrong for silly reasons. It cannot remove the chance that you are wrong for commercial reasons.

That second kind of wrongness is part of leadership.

And once a company starts admitting that, another pressure appears almost immediately. Because if the decision can no longer be postponed by asking for more evidence, the next argument moves somewhere many businesses still find uncomfortable.

It moves into the work itself - into what kind of ideas and creative choices the company is actually willing to back.